mPATH Health is thrilled to announce the successful closure of $3 million in funding, which will accelerate the company's mission to enhance cancer prevention and improve health equity. This funding includes a $2 million Small Business Technology Grant from the National Cancer Institute (NCI) and a $1 million equity investment led by Oncology Ventures, an oncology-focused venture capital firm.

mPATH Health is a digital health company dedicated to transforming preventive cancer screening by integrating automation and behavioral science.